Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Aggravated Sedation in COVID-19 ARDS Patients Using Electroencephalography

NCT04815109 is registered in ClinicalTrials.gov with Goethe University as lead sponsor.

NCT NCT04815109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04815109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Aggravated Sedation in COVID-19 ARDS Patients Using Electroencephalography
Lead sponsor
Goethe University
Phase
Observational
Overall status
Completed
Start date
April 1, 2021
Completion date
June 30, 2022
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, conscious sedation, corona virus infection, electroencephalogram, pathologic processes